Agenda and minutes

Venue: Committee Room 1 - Senedd

Contact: Policy: Llinos Dafydd  / Legislation: Fay Buckle

Items
Note No. Item

1.

Introductions, apologies and substitutions

Minutes:

1.1 Apologies were received from Vaughan Gething and Darren Millar.  There were no substitutions.

 

(09.30 - 12.10)

2.

Inquiry into the implementation of the NSF for diabetes in Wales and its future direction - Oral evidence

2a

09.30 - 10.20: Diabetes UK Cymru

HSC(4)-30-12 paper 1 – Evidence from Diabetes UK Cymru

          Dai Williams, Director, Diabetes UK Cymru

Jason Harding, Policy Manager, Diabetes UK Cymru

Supporting documents:

Minutes:

2.1 The witnesses responded to questions from members of the Committee.

2b

10.20 - 11.10: Royal College of Physicians, Association of British Clinical Diabetologists, and British Medical Association

HSC(4)-30-12 paper 2 – Evidence from the Royal College of Physicians and the Association of British Clinical Diabetologists

Dr Meurig Williams, Royal College of Physicians Regional Adviser for Wales

Dr Aled Roberts, Association of British Clinical Diabetologists

HSC(4)-30-12 paper 3 – Evidence from the British Medical Association

          Dr Ian Millington

Dr Mark Temple

Supporting documents:

Minutes:

2.2 The witnesses responded to questions from members of the Committee.

 

2.3 Dr Temple agreed to provide a note for the Committee on the reduction in the number of public health doctors in Wales over recent years.

2c

11.20 - 12.10: Royal Pharmaceutical Society and Community Pharmacy Wales

HSC(4)-30-12 paper 4 – Evidence from the Royal Pharmaceutical Society

          Mair Davies, Chair, Welsh Pharmacy Board

          Paul Gimson, Director for Wales, Royal Pharmaceutical Society

HSC(4)-30-12 paper 5 – Evidence from Alliance Boots

Russell Goodway, Chief Executive, Community Pharmacy Wales

Marc Donovan, Community Pharmacy Wales Board Member and Head of Professional Capability, Alliance Boots

         

 

Supporting documents:

Minutes:

2.4 The witnesses responded to questions from members of the Committee.

 

2.5 Mr Gimson agreed to share with the Committee a paper on the results of pharmacists providing structured education for diabetes patients.

 

(12.10 - 12.15)

3.

Papers to note

Minutes of the meetings held on 17 & 25 October, and 7 November

Supporting documents:

3a

Forward Work Programme - November to December 2012

HSC(4)-30-12 paper 6

Supporting documents:

Minutes:

3.1 The Committee noted the paper.

 

3.2 The Committee agreed to seek time early in 2013 to meet with the National Clinical Forum, the Wales Deanery and other national organisations to continue its consideration of health board service reconfiguration plans.

3b

Correspondence from Mick Antoniw AM on the Recovery of Medical Costs for Asbestos Diseases (Wales) Bill

HSC(4)-30-12 paper 7

Supporting documents:

Minutes:

3.3 The Committee noted the letter.

 

3.4 Mick Antoniw informed the Committee that, as the Member in Charge of the Bill, he would not attend the Committee sessions at which the Bill would be considered.

3c

Correspondence from the Leader of the House on the Smoke Free Premises (Amendment) (Wales) Regulations

HSC(4)-30-12 paper 8

Supporting documents:

Minutes:

3.5 The Committee noted the letter.

(12.15)

4.

Motion under Standing Order 17.42(vi) to exclude the public from this meeting for item 5 and for the meeting on 21 November for item 1

Minutes:

4.1 The Committee agreed the Motion.

(13.15 - 14.30)

5.

Inquiry into Residential Care for Older People - Consideration of draft report

Minutes:

5.1 The Committee considered the draft report and agreed to schedule a session to consider it again on 21 November.

Transcript

 

 

You are in :

  1. Home
  2. Senedd Business

Partners & Help